Autor: Valentin K. Gribkoff, Elizabeth A. Jonas, J. Marie Hardwick
Wydawca: Wiley
Dostępność: 3-6 tygodni
Cena: 888,30 zł
Przed złożeniem zamówienia prosimy o kontakt mailowy celem potwierdzenia ceny.
ISBN13: |
9781118709238 |
ISBN10: |
1118709233 |
Autor: |
Valentin K. Gribkoff, Elizabeth A. Jonas, J. Marie Hardwick |
Oprawa: |
Hardback |
Rok Wydania: |
2015-11-24 |
Ilość stron: |
448 |
Wymiary: |
232x169 |
Tematy: |
MJ |
The powerhouses of cells, mitochondria are responsible for generating energy, regulation of cellular homeostasis and and are involved in cell death–signaling pathways. A wide range of neurological disorders – such as Alzheimer’s, Parkinson’s, schizophrenia, bipolar disease, migraines, and strokes – have all been traced back to the accumulation of mitochondrial DNA (mtDNA) damage or mitochondrial dysfunction.
Focusing on neuronal mitochondria, this book discusses their functions and properties, and the relation of dysfunctional mitochondria to neuronal disease, and to the future development of new therapies. For scientists and researchers in both industry and academia, the expert contributors provide detailed discussions, examples, and approaches to illustrate the potential of mitochondria as therapeutic targets for neuronal diseases – like Alzheimer’s, Parkinson’s, strokes, and brain trauma. Together, these chapters offer the tools and perspectives to help decipher challenges and develop strategies for more targeted therapeutic approaches and, potentially, for personalized treatments.
Using recent evidence and examples of drugs, targeted approaches, and an in–depth understanding of cell death; this book:
• Presents up–to–date information and advances in the field of neuronal mitochondria, including the promise of future therapeutics
• Helps readers understand the regulation of mitochondrial cellular processes, such as substrate metabolism, energy production, and programmed verses sporadic cell death
• Includes examples of mitochondrial drugs, development, and mitochondria–targeted approaches for more efficient treatment methods and further developments in the field
• Covers the development of existing and emerging therapeutic approaches for neuronal disorders that may in the future become critical components of modern therapeuticsValentin Gribkoff is the former Chief Scientific Officer and Senior Vice President of Discovery Research at Knopp Neurosciences as well as a scientific consultant for pharmaceutical companies. He is currently a Visiting Research Scientist in the Department of Medicine at Yale University School of Medicine and a Founding Member of the Northwoods Group, a Biotech Consultant/Development group. He co–edited the book Structure, Function and Modulation of Neuronal Voltage–Gated Ion Channels (Wiley 2009) and is Series Editor for the Wiley Series on Neuropharmacology.
Elizabeth Jonas is an Associate Professor at the Departments of Internal Medicine, Section of Endocrinology, and Neurobiology at Yale University School of Medicine.
J. Marie Hardwick is the David Bodian Professor of Molecular Microbiology and Immunology at The Johns Hopkins Bloomberg School of Public Health.
Książek w koszyku: 0 szt.
Wartość zakupów: 0,00 zł
Gambit
Centrum Oprogramowania
i Szkoleń Sp. z o.o.
Al. Pokoju 29b/22-24
31-564 Kraków
Siedziba Księgarni
ul. Kordylewskiego 1
31-542 Kraków
+48 12 410 5991
+48 12 410 5987
+48 12 410 5989
Administratorem danych osobowych jest firma Gambit COiS Sp. z o.o. Na podany adres będzie wysyłany wyłącznie biuletyn informacyjny.
© Copyright 2012: GAMBIT COiS Sp. z o.o. Wszelkie prawa zastrzeżone.
Projekt i wykonanie: Alchemia Studio Reklamy